Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders
whose prevalence rates are expected to rise worldwide, corresponding to aging and …

While non-alcoholic fatty liver disease (NAFLD) is a prevalent and frequent cause of liver-
related morbidity and mortality, it is also strongly associated with cardiovascular disease …

There is a scarcity of studies on the interactions between heavy metals and non-alcoholic
fatty liver disease (NAFLD). Using a variety of statistical approaches, we investigated the …

Background The alanine aminotransferase (ALT)/aspartate aminotransferase (AST) ratio
has been considered an alternative marker for hepatic steatosis. However, few studies have …

Environmental pollutants have been known to increase the risks of not only respiratory and
cardiovascular disease but also metabolic diseases such as obesity and diabetes mellitus …

There is a scarcity of research on the effects of a mixture of chemicals on liver function
biomarkers and non-alcoholic fatty liver disease (NAFLD) indices, including FSI, HIS, and …

Multiple animals and in vitro studies have demonstrated that perfluoroalkyl and
polyfluoroalkyl substances (PFASs) exposure causes liver damage associated with fat …

The experimental evidences linking PM 2.5 exposure to weight status disorder and the
associated mechanisms were lacked. Here, we demonstrated exposure of 198.52 μg/m 3 …

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with the metabolic syndrome
and type 2 diabetes and independently contributes to long-term complications. Being often …

Etiology of hepatic steatosis and metabolic dysfunction-associated fatty liver disease
(MAFLD) among acute coronary syndrome (ACS) remains unclear. Existing studies …